Treatment of actinic keratosis with tirbanibulin in private practice dermatology. Our experience in terms of efficacy and patient perception

to be much/somewhat improved and 92% of physicians and 89% of patients were extremely/very satisfied or satisfied with tirbanibulin to improve "how skin looks" and "skin texture".Moreover, 88% of physicians and 82% of patients reported tirbanibulin to be much/ somewhat better compared with previous topical treatment.87% of physicians and 86% of patients reported likelihood to consider tirbanibulin again, if needed.Figure 2. Clinical clearance at baseline, Day 8 and Day 57 with use of tirbanibulin for actinic keratoses on face: 55 years-old woman with 5 lesions at baseline.No LTS.CC at Day 57.Conclusions: Physicians' and patients' overall satisfaction with tirbanibulin was high, and both reported great likelihood to use tirbanibulin in future.These results are comparable to previous ones [2].

Authors

Institutions

Publication Details

Journal
EJC Skin Cancer
Published
2025-01-01
DOI
https://doi.org/10.1016/j.ejcskn.2025.100301
Citations
1
Primary Topic
Nonmelanoma Skin Cancer Studies
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment of actinic keratosis with tirbanibulin in private practice dermatology. Our experience in terms of efficacy and patient perception

Antonio Olveira, Paulo Varela
1 citations
EJC Skin Cancer
Nonmelanoma Skin Cancer Studies
1.35
article

Treatment of actinic keratosis with tirbanibulin in private practice dermatology. Our experience in terms of efficacy and patient perception

Antonio Olveira, Paulo Varela
article en
1 citations

Abstract

to be much/somewhat improved and 92% of physicians and 89% of patients were extremely/very satisfied or satisfied with tirbanibulin to improve "how skin looks" and "skin texture".Moreover, 88% of physicians and 82% of patients reported tirbanibulin to be much/ somewhat better compared with previous topical treatment.87% of physicians and 86% of patients reported likelihood to consider tirbanibulin again, if needed.Figure 2. Clinical clearance at baseline, Day 8 and Day 57 with use of tirbanibulin for actinic keratoses on face: 55 years-old woman with 5 lesions at baseline.No LTS.CC at Day 57.Conclusions: Physicians' and patients' overall satisfaction with tirbanibulin was high, and both reported great likelihood to use tirbanibulin in future.These results are comparable to previous ones [2].

EJC Skin CancerVol. 3
Universidad de Málaga (ES)
Openalex Percentile: Top 21%
Nonmelanoma Skin Cancer Studies
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Treatment of actinic keratosis with tirbanibulin in private practice dermatology. Our experience in terms of efficacy and patient perception — Antonio Olveira, Paulo Varela · EJC Skin Cancer (2025) | TGRS Research Map | TGRS